EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) revenue breakdown overview

EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) revenue for the last year amounted to 5.38 B EGP, the most of which — 5.23 B EGP — came from its highest performing source at the moment, Antibiotics, Lyophilized Products and Spansule Capsules, the year earlier bringing 3.96 B EGP. The greatest contribution to the revenue figure was made by Egypt — last year it brought EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) 5.23 B EGP, and the year before that — 3.96 B EGP.